Craving Assessment in Patients With Alcohol Use Disorder Using Virtual Reality Exposure
Key facts
- Who runs it
- Charite University, Berlin, Germany
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 61 people enrolled
- Started
- 23 Sept 2023
- Ended
- 30 Jun 2024
- Type of study
- Observational
- Treatments tested
- Virtual Reality-based cue exposure paradigm
- Record updated
- 26 August 2024
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- age: 18-65 years
- diagnosis of alcohol dependence according to ICD-10 (F10.2)
- completed in-patient withdrawal treatment during the last 3 months
- history of alcohol craving, confirmed via craving questionnaires
- able to provide written informed consent
Who cannot take part
- concurrent pharmacological treatment targeting AUD (i.e. benzodiazepines) or craving (i.e. acamprosate, disulfiram, naltrexone, nalmefene) and further medication significantly influencing heart frequency
- severe neuropsychiatric disorder, e.g. schizophrenia spectrum disorders, bipolar affective disorder or substantial cognitive impairment
- serious illnesses influencing brain-/heart-function with influence on physiological study parameters
- substance dependence other than alcohol and nicotine
- current alcohol intoxication (randomly tested via measurement of breath alcohol concentration)
- unable to understand the study information, consent form or principles of the study
- abstinence for less than 7 days or on-going consumption of alcohol
- acute suicidality (or acute endangerment of others)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Alcohol use disorder (AUD) is a burdensome clinical disorder with high relapse rates. Virtual Reality (VR)-based therapeutic and diagnostic approaches have received increasing attention in the treatment of AUD but evidence on the induction of craving via VR scenarios is still needed. Craving for alcohol is associated with psychological and physiological responses. This single-arm clinical study will be conducted including n=60 patients with AUD. Using a head-mounted display (HMD), patients will be confronted with three different VR scenarios (neutral vs. two target situations) while heart rate, heart rate variability (HRV), pupillometry and electrodermal activity (EDA) will be measured continuously. Subjective craving levels will be assessed pre-/during/post-exposure to each VR scenario.
Treatments tested
- Virtual Reality-based cue exposure paradigm
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Predictors of subjective and physiological craving during VR-cue exposure in alcohol use disorder: an explorative single-arm clinical study.BMC psychiatry, 2026
- An explorative single-arm clinical study to assess craving in patients with alcohol use disorder using Virtual Reality exposure (CRAVE)-study protocol.BMC psychiatry, 2023
- Record updated
- 26 August 2024